HealthSiliconANGLEabout 1 hour ago
Pathos AI Closes $237M Series E Round
3 min read
Pathos AI Inc. announced today it raised $237 million in a Series E round led by Bristol Myers Squibb Co. at a $3 billion valuation. The startup uses its Foundry AI platform to develop cancer drugs, accessing 200 petabytes of oncological data.
Level
Hype check
Tap to vote and see what everyone thinks.
